Press Releases

Press Releases

Shire plc announced that it will expand its operations in Cambridge, Massachusetts, establishing a rare disease innovation hub and increasing its footprint in the heart of Kendall Square. Shire and BioMed Realty have signed a lease for a 343,000-square-foot building at 500 Kendall Street. Shire's lease begins in Q3, 2018,…

Press Releases

Absorption Systems, a world leader in novel test systems for drug transporters, announces the renewal of a technology licensing deal with Biogen. After years of contract testing by Absorption Systems using MDR1-MDCK cells, Biogen licensed the technology associated with the test system from Absorption Systems in October 2015 and is…

Press Releases

TKL Research, a dermatology specialty clinical research organization (CRO), announced today that it has signed an agreement to sell its Clinical Trials Division (CTD) to QuintilesIMS. Upon closing, TKL’s CTD will become part of Novella Clinical, a Quintiles company. Moving forward, TKL Research will retain its Research Clinics Division (RCD)…

Tuesday, Nov 22, 2016
Press Releases

Boost your business in 2017 by presenting your solutions to the top pharmaceutical and biotechnology decision makers in Central Eastern Europe! TEG -  organizer of the most important pharmaceutical and and biotechnology business summit in CEE Pharm Connect Congress, with the support of the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ) -…

Press Releases

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT:IMUC) announced the presentation of updated immune monitoring data from the phase 2 trial of ICT-107 in patients with newly diagnosed glioblastoma. Also presented were updated long-term survival data from the phase 1 trial of ICT-107. ICT-107 is a dendritic cell-based immunotherapy targeting multiple tumor-associated…

Press Releases

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced the issuance of a United States patent covering OXAYDO® (oxycodone HCI, USP) tablets for oral use only–CII.  Egalet licensed OXAYDO from Acura Pharmaceuticals and launched the product…

Press Releases

BioSpecifics Technologies Corp., a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product collagenase clostridium histolyticum, or CCH, marketed as XIAFLEX® in the U.S. and Xiapex® in Europe today announced positive, highly statistically significant results from a Phase 2b study of CCH…

Press Releases

Peptide delivery represents a highly debated area of scientific research that is currently receiving lots of attention. In the past few years, peptides were administered via injections, but the industry is now increasingly aware of the significance of the oral route due to higher levels of patient acceptance. The advances…

Press Releases

TNK Therapeutics, Inc. ("TNK"), a subsidiary of Sorrento Therapeutics, Inc., has entered into a binding term sheet to acquire Virttu Biologics Limited ("Virttu"). Virttu, based in Glasgow, Scotland, is a privately-held biopharmaceutical company focused on the development of oncolytic virus therapy for treatment of cancer. Virttu's lead product candidate Seprehvir®…

Press Releases

Cumberland Pharmaceuticals, a U.S. specialty pharmaceutical company has entered into an Agreement to acquire the exclusive U.S. rights to Nordic Group B.V.'s innovative injectable methotrexate product line. The products are designed for the treatment of active rheumatoid arthritis, juvenile idiopathic arthritis, severe psoriatic arthritis, and severe disabling psoriasis. The product…